Zongertinib (BI 1810631)

Zongertinib · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zongertinib (BI 1810631), covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body [Phase 1]